(Q37569325)

21 August 2017

1 reference

title

Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty (English)

1 reference

21 August 2017

1 reference

venous thromboembolism

1 reference

Bengt I Eriksson

1

1 reference

21 August 2017

Richard J Friedman

series ordinal

2

1 reference

21 August 2017

publication date

31 July 2009

1 reference

Clinical and Applied Thrombosis-Hemostasis

21 August 2017

published in

1 reference

21 August 2017

volume

15 Suppl 1

1 reference

21 August 2017

page(s)

25S-31S

1 reference

Structure-based design of novel potent nonpeptide thrombin inhibitors

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1076029609340668

Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609340668

Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609340668

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609340668

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609340668

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609340668

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609340668

Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609340668

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029609340668

21 January 2018

Identifiers

DOI

10.1177/1076029609340668

1 reference

21 August 2017

1 reference